NCT01336855 Collection of Blood for Multiple Collaborative Studies
| NCT ID | NCT01336855 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | HIV |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 1988-01 |
| Primary Completion | 2030-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 1988-01 with a primary completion date of 2030-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study seeks to confidentially collect blood from HIV-positive individuals and HIV-negative controls to provide basic scientists with specimens for collaborative studies.
Eligibility Criteria
Inclusion Criteria: * HIV-1 antibody negative with similar characteristics to HIV-1 positive cohort * HIV-positive subjects naive to antiretroviral therapy * HIV-positive subjects stable on or off antiretroviral therapy for a minimum of 6 months * Good venous access * Able to provide informed consent Exclusion Criteria: * Hemoglobin \< 9g/dl * Hematocrit \< 27% * Active treatment for cancer * Hospitalization or IV antibiotic use within the last 4 months * Immunosuppressive therapy within the last 4 months
Contact & Investigator
Steven Deeks, M.D.
PRINCIPAL INVESTIGATOR
University of Californa, San Francisco
Frequently Asked Questions
Who can join the NCT01336855 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01336855 currently recruiting?
Yes, NCT01336855 is actively recruiting participants. Contact the research team at Rebecca.Hoh@ucsf.edu for enrollment information.
Where is the NCT01336855 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT01336855 clinical trial?
NCT01336855 is sponsored by University of California, San Francisco. The principal investigator is Steven Deeks, M.D. at University of Californa, San Francisco. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.